Connective tissues disease-associated lung disease

P. Markart (Giessen, Germany)

Source: School Course 2014 - Interstitial lung diseases
Number: 10
Disease area: Interstitial lung diseases

PDF journal article, handout or slidesPDF journal article, handout or slides

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Markart (Giessen, Germany). Connective tissues disease-associated lung disease. School Course 2014 - Interstitial lung diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Connective tissue disease-associated lung disease
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Connective tissue disease-associated lung disease
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


Connective tissue disease-associated lung disease
Source: ERS Course 2019- Interstitial Lung Diseases
Year: 2018

Connective tissue disease-associated lung disease
Source: ERS Course 2016
Year: 2016




Connective tissue disease-associated lung disorders
Source: Eur Respir Mon; 2009: 46: 225–250
Year: 2009

Connective tissue disease-associated ILD
Source: International Congress 2018 – State of the art session: Interstitial lung diseases
Year: 2018


Connective tissue disease-related interstitial lung disease and lung cancer
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


Connective tissue diseases, multimorbidity and the ageing lung
Source: Eur Respir J 2016; 47:1535-1558
Year: 2016



Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Connective tissue disease-associated interstitial lung diseases and interstitial pneumonia with autoimmune features: different entities?
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Disease patterns in connective tissue disease-associated interstitial lung disease: a population based study
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Anti periplakin antibodies in connective tissue-associated lung fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Interstitial lung disease in the connective tisssue disease
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014


Case-based imaging of connective tissue disease-related lung disease
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021


Chemical exposure triggering connective tissue disease with lung involvement
Source: International Congress 2015 – Occupational disease: clinical cases and series
Year: 2015


Plethysmographic profil of patients with infiltrative lung diseases
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Evaluation and treatment of interstitial lung involvement in connective tissue diseases: a clinical update
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=27
Year: 2005

Endothelin-1 induced connective tissue growth factor expression in human lung fibroblasts by ETAR-dependent JNK/AP-1 pathway
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013